This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovations of Eric C. Brieinlinger
Introduction
Eric C. Brieinlinger is an accomplished inventor based in Charlton, Massachusetts. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential therapeutic applications. His work focuses on creating innovative solutions to address various medical conditions.
Latest Patents
Eric holds a patent for "Imidazo based heterocycles." This invention is directed towards novel imidazopyrazine and imidazopyrimidine compounds, which are useful as kinase inhibitors. These compounds are particularly valuable in treating inflammatory conditions, diseases, and proliferative disorders, including cancers. His patent portfolio includes 1 patent that showcases his expertise in this area.
Career Highlights
Eric is currently employed at Abbott Laboratories Corporation, a leading global healthcare company. His role involves research and development, where he applies his knowledge to create innovative solutions in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic strategies.
Collaborations
Throughout his career, Eric has collaborated with notable colleagues, including David J. Calderwood and Kristine E. Frank. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Eric C. Brieinlinger exemplifies the spirit of innovation in the field of chemistry. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.